69 related articles for article (PubMed ID: 8886616)
1. Disposition of metabolically radiolabeled CE9.1--a macaque-human chimeric anti-human CD4 monoclonal antibody--in transgenic mice bearing human CD4.
Davis CB; Garver EM; Kwok DC; Urbanski JJ
Drug Metab Dispos; 1996 Sep; 24(9):1032-7. PubMed ID: 8886616
[TBL] [Abstract][Full Text] [Related]
2. Subcutaneous bioavailability of a PRIMATIZED IgG1 anti-human CD4 monoclonal antibody is dose dependent in transgenic mice bearing human CD4.
Davis CB; Bugelski PJ
Drug Deliv; 1998; 5(2):95-100. PubMed ID: 19570000
[TBL] [Abstract][Full Text] [Related]
3. Disposition of metabolically labeled recombinant soluble CD4 (sT4) in male Sprague-Dawley rats following intravenous and subcutaneous administration.
Davis CB; Boyle KE; Urbanski JJ; Paradysz RT; Fong KL
Drug Metab Dispos; 1992; 20(5):695-705. PubMed ID: 1358574
[TBL] [Abstract][Full Text] [Related]
4. Comparative pharmacodynamics of keliximab and clenoliximab in transgenic mice bearing human CD4.
Sharma A; Davis CB; Tobia LA; Kwok DC; Tucci MG; Gore ER; Herzyk DJ; Hart TK
J Pharmacol Exp Ther; 2000 Apr; 293(1):33-41. PubMed ID: 10734150
[TBL] [Abstract][Full Text] [Related]
5. A primatized MAb to human CD4 causes receptor modulation, without marked reduction in CD4+ T cells in chimpanzees: in vitro and in vivo characterization of a MAb (IDEC-CE9.1) to human CD4.
Anderson D; Chambers K; Hanna N; Leonard J; Reff M; Newman R; Baldoni J; Dunleavy D; Reddy M; Sweet R; Truneh A
Clin Immunol Immunopathol; 1997 Jul; 84(1):73-84. PubMed ID: 9191886
[TBL] [Abstract][Full Text] [Related]
6. Rapid and specific targeting of 125I-labeled B lymphocyte stimulator to lymphoid tissues and B cell tumors in mice.
Riccobene TA; Miceli RC; Lincoln C; Knight Y; Meadows J; Stabin MG; Sung C
J Nucl Med; 2003 Mar; 44(3):422-33. PubMed ID: 12621010
[TBL] [Abstract][Full Text] [Related]
7. Clinical and immunologic effects of a PRIMATIZED anti-CD4 monoclonal antibody in active rheumatoid arthritis: results of a phase I, single dose, dose escalating trial.
Yocum DE; Solinger AM; Tesser J; Gluck O; Cornett M; O'Sullivan F; Nordensson K; Dallaire B; Shen CD; Lipani J
J Rheumatol; 1998 Jul; 25(7):1257-62. PubMed ID: 9676753
[TBL] [Abstract][Full Text] [Related]
8. Biological activities on T lymphocytes of a baculovirus-expressed chimeric recombinant IgG1 antibody with specificity for the CDR3-like loop on the D1 domain of the CD4 molecule.
Troadec S; Bès C; Chentouf M; Nguyen B; Briant L; Jacquet C; Chebli K; Pugnière M; Roquet F; Cerutti M; Chardès T
Clin Immunol; 2006 Apr; 119(1):38-50. PubMed ID: 16426893
[TBL] [Abstract][Full Text] [Related]
9. Differential effects of administration of a human anti-CD4 monoclonal antibody, HM6G, in nonhuman primates.
Fishwild DM; Hudson DV; Deshpande U; Kung AH
Clin Immunol; 1999 Aug; 92(2):138-52. PubMed ID: 10444358
[TBL] [Abstract][Full Text] [Related]
10. PEGylation of poly(ethylene imine) affects stability of complexes with plasmid DNA under in vivo conditions in a dose-dependent manner after intravenous injection into mice.
Merdan T; Kunath K; Petersen H; Bakowsky U; Voigt KH; Kopecek J; Kissel T
Bioconjug Chem; 2005; 16(4):785-92. PubMed ID: 16029019
[TBL] [Abstract][Full Text] [Related]
11. NTP Toxicology and Carcinogenesis Studies of Pentachloroanisole (CAS No. 1825-21-4) in F344 Rats and B6C3F1 Mice (Feed Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1993 Apr; 414():1-284. PubMed ID: 12616284
[TBL] [Abstract][Full Text] [Related]
12. NTP Toxicology and Carcinogenesis Studies of 1-Amino-2,4-Dibromoanthraquinone (CAS No. 81-49-2) in F344/N Rats and B6C3F1 Mice (Feed Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1996 Aug; 383():1-370. PubMed ID: 12692653
[TBL] [Abstract][Full Text] [Related]
13. NTP technical report on the toxicity and metabolism studies of chloral hydrate (CAS No. 302-17-0). Administered by gavage to F344/N rats and B6C3F1 mice.
Beland FA
Toxic Rep Ser; 1999 Aug; (59):1-66, A1-E7. PubMed ID: 11803702
[TBL] [Abstract][Full Text] [Related]
14. A therapeutic anti-CD4 monoclonal antibody inhibits T cell receptor signal transduction in mouse autoimmune cardiomyopathy.
Wang ZH; Liao YH; Yuan J; Zhang L; Wang M; Zhang JH; Liu ZP; Dong JH
Chin Med J (Engl); 2007 Aug; 120(15):1319-25. PubMed ID: 17711737
[TBL] [Abstract][Full Text] [Related]
15. Targeting strategies for cancer radiotherapy.
Buchsbaum DJ; Rogers BE; Khazaeli MB; Mayo MS; Milenic DE; Kashmiri SV; Anderson CJ; Chappell LL; Brechbiel MW; Curiel DT
Clin Cancer Res; 1999 Oct; 5(10 Suppl):3048s-3055s. PubMed ID: 10541342
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics and metabolism in mice of a phosphorothioate oligonucleotide antisense inhibitor of C-raf-1 kinase expression.
Geary RS; Leeds JM; Fitchett J; Burckin T; Truong L; Spainhour C; Creek M; Levin AA
Drug Metab Dispos; 1997 Nov; 25(11):1272-81. PubMed ID: 9351904
[TBL] [Abstract][Full Text] [Related]
17. Targeting rat anti-mouse transferrin receptor monoclonal antibodies through blood-brain barrier in mouse.
Lee HJ; Engelhardt B; Lesley J; Bickel U; Pardridge WM
J Pharmacol Exp Ther; 2000 Mar; 292(3):1048-52. PubMed ID: 10688622
[TBL] [Abstract][Full Text] [Related]
18. A population pharmacokinetic-pharmacodynamic analysis of single doses of clenoliximab in patients with rheumatoid arthritis.
Mould DR; Davis CB; Minthorn EA; Kwok DC; Elliott MJ; Luggen ME; Totoritis MC
Clin Pharmacol Ther; 1999 Sep; 66(3):246-57. PubMed ID: 10511060
[TBL] [Abstract][Full Text] [Related]
19. Clinical evaluation of indium-111-labeled chimeric anti-CEA monoclonal antibody.
Wong JY; Thomas GE; Yamauchi D; Williams LE; Odom-Maryon TL; Liu A; Esteban JM; Neumaier M; Dresse S; Wu AM; Primus FJ; Shively JE; Raubitschek AA
J Nucl Med; 1997 Dec; 38(12):1951-9. PubMed ID: 9430476
[TBL] [Abstract][Full Text] [Related]
20. Assessment of the radiochemical design of antibodies with a metabolizable linkage for target-selective radioactivity delivery.
Arano Y; Wakisaka K; Akizawa H; Ono M; Kawai K; Nakayama M; Sakahara H; Konishi J; Saji H
Bioconjug Chem; 1998; 9(4):497-506. PubMed ID: 9667952
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
